It has come to our attention that beneficiaries are experiencing difficulties getting prescriptions for doxycycline filled. Drug shortages and availability issues have created significant price increases for the hyclate formulation. Reimbursement of doxycycline hyclate is based upon the federal upper limits (FUL) which cannot be overridden.
However, doxycycline monohydrate is a readily available formulation without an assigned federal upper limit (FUL).
As an option for our beneficiaries and providers, the following doxycycline monohydrate formulations have been moved to preferred status. We encourage providers to prescribe, stock and dispense doxycycline monohydrate when appropriate for their Medicaid beneficiaries:
Doxycycline Monohydrate 50mg caps:
Doxycycline Monohydrate 100mg caps: